CME Group Inc. $CME is Fiera Capital Corp’s 9th Largest Position

Fiera Capital Corp trimmed its stake in CME Group Inc. (NASDAQ:CME) by 3.9% in the 4th quarter, HoldingsChannel reports. The firm owned 2,635,814 shares of the financial services provider’s stock after selling 108,292 shares during the period. CME Group makes up 2.3% of Fiera Capital Corp’s portfolio, making the stock its 9th largest holding. Fiera Capital Corp’s holdings in CME Group were worth $719,788,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Syon Capital LLC increased its stake in shares of CME Group by 8.5% in the 4th quarter. Syon Capital LLC now owns 4,613 shares of the financial services provider’s stock worth $1,260,000 after purchasing an additional 362 shares in the last quarter. Capital Research Global Investors increased its stake in shares of CME Group by 0.7% in the 4th quarter. Capital Research Global Investors now owns 1,062,343 shares of the financial services provider’s stock worth $290,105,000 after purchasing an additional 7,716 shares in the last quarter. Capital International Investors increased its stake in shares of CME Group by 2.1% in the 4th quarter. Capital International Investors now owns 4,197,668 shares of the financial services provider’s stock worth $1,146,593,000 after purchasing an additional 87,411 shares in the last quarter. Dearborn Partners LLC increased its stake in shares of CME Group by 712.2% in the 4th quarter. Dearborn Partners LLC now owns 94,608 shares of the financial services provider’s stock worth $25,835,000 after purchasing an additional 82,960 shares in the last quarter. Finally, Greykasell Wealth Strategies Inc. purchased a new stake in shares of CME Group in the 4th quarter worth $73,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CME has been the subject of several analyst reports. Erste Group Bank lowered CME Group from a “buy” rating to a “hold” rating in a research note on Friday. JPMorgan Chase & Co. upped their price objective on CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. Rothschild & Co Redburn reduced their price objective on CME Group from $340.00 to $316.00 and set a “neutral” rating for the company in a research note on Monday, April 27th. Weiss Ratings restated a “buy (a-)” rating on shares of CME Group in a research report on Friday, May 29th. Finally, TD Cowen decreased their price objective on shares of CME Group from $340.00 to $323.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $305.29.

Insider Buying and Selling at CME Group

In other news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the transaction, the general counsel owned 7,192 shares of the company’s stock, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 44,044 shares of company stock valued at $13,297,507 in the last 90 days. Insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of CME stock opened at $257.40 on Monday. CME Group Inc. has a 52-week low of $244.56 and a 52-week high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm has a market capitalization of $93.27 billion, a PE ratio of 21.96, a PEG ratio of 2.88 and a beta of 0.21. The stock has a fifty day simple moving average of $288.35 and a two-hundred day simple moving average of $288.67.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business had revenue of $1.88 billion during the quarter, compared to analyst estimates of $1.77 billion. During the same quarter in the prior year, the business posted $2.80 EPS. CME Group’s revenue for the quarter was up 14.5% compared to the same quarter last year. On average, analysts predict that CME Group Inc. will post 12.28 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date is Tuesday, June 9th. CME Group’s dividend payout ratio is presently 44.37%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.